Patents by Inventor Matthias Stauffenbiel

Matthias Stauffenbiel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tau hyperphosphorylation in transgenic mice expressing the APP double mutation
    Patent number: 7663018
    Abstract: Animal model involving transgenic manipulation of amyloid precursor protein, useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: February 16, 2010
    Assignee: Novartis AG
    Inventors: Bernd Sommer, Matthias Stauffenbiel
  • Transgenic animal model for Alzheimer's disease
    Publication number: 20070022483
    Abstract: Animal model involving transgenic manipulation of amyloid precursor protein, useful for testing potential therapeutic agents for the treatment of neurodegenerative disorders, in particular Alzheimer's disease.
    Type: Application
    Filed: April 28, 2006
    Publication date: January 25, 2007
    Inventors: Bernd Sommer, Matthias Stauffenbiel